Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#3800 Correlation between early response and lesion dosimetry in patients with advanced neuroendocrine tumor (NET) treated with radioligand therapy (RLT)

Introduction: The identification of predictive parameters of response to radioligand therapy (RLT) in NET patients is essential in order to avoid futile therapy toxicities. The relation between the tumor absorbed dose and therapy response has so far not been established.

Conference:

Presenting Author: Durmo R

Authors: Durmo R, Fioroni F, Grassi E, Coruzzi C, Giulia B,

Keywords: RLT, Dosimetry,

#3589 Evaluation of interim Dotatate-PET after two cycles of Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NET)

Introduction: Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE is a targeted radionuclide treatment for patients with neuroendocrine tumors (NET).

Conference:

Presenting Author: Duan H

Authors: Duan H, Song H, Ferri V, Fisher G, Shaheen S,

Keywords: PRRT, NET, Dotatate, PET, early response, Pseudo-progression,

#3207 What role for the interim PET/CT with 68Ga-DOTA peptides in the evaluation of the early response to PRRT?

Introduction: Early evaluation by PET/CT during therapy has an important predictive value of the final response in some tumors (e.g. lymphomas).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Durmo R, Cervati V, Finocchiaro D, Filice A, Casali M,

Keywords: PRRT, PET/CT,

#3001 Early Response Assessment for Prediction of Overall Survival after Peptide Receptor Radionuclide Therapy

Introduction: PRRT response assessment is performed using RECIST, yet functional assessment using 68Ga-DOTATATE PET/CT and plasma CgA might give additional information about prediction of overall survival (OS).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Huizing D, Aalbersberg E, Versleijen M, Tesselaar M, Walraven I,

Keywords: PRRT, RECIST, 68Ga-DOTATATE PET/CT, response,